Skip Navigation

European Heart Journal 1993 14(10):1427-1433;
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The Europen Society of Cardiology

Treatment of atrial fibrillation

Recommendations from a workshop arranged by the Medical Products Agency (Uppsala, Sweden) and the Swedish Society of Cardiology

revised 1 April 1993; accepted 18 September 1992.

Abstract

Atrial fibrillation may be paroxysmal or chronic. The paroxysmal form presents in the form of attacks of short duration but may last for up to 3–4 days. Episodes of atrial fibrillation of longer duration are considered as chronic. The diagnosis is made by ECG.

Key Words: Acetylsalicylic acid • amiodarone • atrial fibrillation • DC conversion • digoxin • diltiazem • disopyramide • flecainide • quinidine • sick sinus syndrome • sotalol • stroke • verapamil • warfarin • WPW syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.